Skip to content

ABUS

Arbutus Biopharma Corp

NASDAQ · Healthcare · Biotechnology · US

$4.21
−1.64%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-3.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 23, 2026Androski Lindsay · director, officer: President and CEOM-Exempt116,408$3.20
Sep 23, 2026Androski Lindsay · director, officer: President and CEOM-Exempt10,456$4.39
Sep 23, 2026Androski Lindsay · director, officer: President and CEOF-InKind82,527$5.07
Sep 23, 2026Nguyen Tuan · officer: Chief Financial OfficerM-Exempt265,625$3.49
Sep 23, 2026Beardsley Robert A · directorM-Exempt78,800$4.24
Sep 23, 2026Sawhney Roger · directorM-Exempt78,800$4.24
Sep 23, 2026Sawhney Roger · directorM-Exempt52,533$3.34
Sep 23, 2026Beardsley Robert A · directorF-InKind99,057$5.07
Sep 23, 2026Beardsley Robert A · directorM-Exempt52,533$3.20
Sep 23, 2026Sawhney Roger · directorF-InKind100,508$5.07
Sep 23, 2026Nguyen Tuan · officer: Chief Financial OfficerF-InKind206,637$5.07
Sep 23, 2026Nguyen Tuan · officer: Chief Financial OfficerM-Exempt27,475$4.39
Jun 10, 2026Sawhney Roger · directorA-Award78,800$4.24
Jun 10, 2026Beardsley Robert A · directorA-Award78,800$4.24
Feb 2, 2026Androski Lindsay · director, officer: President and CEOA-Award71,700$4.39
Feb 2, 2026Nguyen Tuan · officer: Chief Financial OfficerA-Award188,400$4.39
Feb 2, 2026Androski Lindsay · director, officer: President and CEOA-Award28,000$0.00
Feb 2, 2026Nguyen Tuan · officer: Chief Financial OfficerA-Award73,500$0.00
Aug 6, 2025Sawhney Roger · directorA-Award157,600$3.34
Apr 1, 2025Nguyen Tuan · officer: Chief Financial OfficerA-Award750,000$3.49
Mar 31, 2025Nguyen Tuan · officer: Chief Financial OfficerA-Award750,000$3.50
Mar 20, 2025Hasija Anuj · directorA-Award157,600$3.20
Mar 20, 2025Beardsley Robert A · directorA-Award157,600$3.20
Mar 20, 2025Androski Lindsay · director, officer: President and CEOA-Award310,422$3.20
Feb 19, 2025McElhaugh Michael J. · director, officer: Interim President & CEOA-Award177,000$0.00
Feb 19, 2025McElhaugh Michael J. · director, officer: Interim President & CEOA-Award718,800$3.29
Feb 19, 2025HASTINGS DAVID C · officer: Chief Financial OfficerA-Award365,800$3.29
Feb 19, 2025HASTINGS DAVID C · officer: Chief Financial OfficerA-Award90,100$0.00
Feb 19, 2025Sims Karen · officer: Chief Medical OfficerA-Award200,300$3.29
Feb 19, 2025Sims Karen · officer: Chief Medical OfficerA-Award49,300$0.00
Institutional positioning

13F filings over the trailing two quarters

New 66Increased 108Reduced 91Sold out 34
FilerActionSharesFiled
MORGAN STANLEYReduced25,891,480May 15, 2026
Two Seas Capital LPIncreased19,095,583Aug 12, 2026
TWO SEAS CAPITAL LPIncreased18,557,543May 15, 2026
MORGAN STANLEYReduced17,698,305Aug 13, 2026
Whitefort Capital Management, LPIncreased15,794,261Aug 14, 2026
WHITEFORT CAPITAL MANAGEMENT, LPIncreased14,930,885May 15, 2026
BlackRock, Inc.Increased13,766,071Aug 7, 2026
BLACKROCK, INC.Reduced12,966,946May 13, 2026
STATE STREET CORPIncreased7,869,179Sep 22, 2026
Rubric Capital Management LPIncreased7,532,937Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased7,010,679Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position6,688,911May 15, 2026
RUBRIC CAPITAL MANAGEMENT LPIncreased6,626,389May 15, 2026
STATE STREET CORPIncreased6,342,510May 15, 2026
BARCLAYS PLCIncreased4,316,095May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 23, 2026